- Home
- MUX vs RGNX Comparison
MUX vs RGNX Comparison
Compare MUX & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- RGNX
- Stock Information
- Founded
- MUX 1979
- RGNX 2008
- Country
- MUX Canada
- RGNX United States
- Employees
- MUX N/A
- RGNX N/A
- Industry
- MUX Precious Metals
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MUX Basic Materials
- RGNX Health Care
- Exchange
- MUX Nasdaq
- RGNX Nasdaq
- Market Cap
- MUX 579.8M
- RGNX 661.2M
- IPO Year
- MUX N/A
- RGNX 2015
- Fundamental
- Price
- MUX $18.55
- RGNX $13.08
- Analyst Decision
- MUX Strong Buy
- RGNX Strong Buy
- Analyst Count
- MUX 4
- RGNX 7
- Target Price
- MUX $19.63
- RGNX $30.00
- AVG Volume (30 Days)
- MUX 2.0M
- RGNX 602.9K
- Earning Date
- MUX 11-07-2025
- RGNX 11-06-2025
- Dividend Yield
- MUX N/A
- RGNX N/A
- EPS Growth
- MUX N/A
- RGNX N/A
- EPS
- MUX N/A
- RGNX N/A
- Revenue
- MUX $168,169,000.00
- RGNX $155,782,000.00
- Revenue This Year
- MUX $5.13
- RGNX $198.02
- Revenue Next Year
- MUX $19.34
- RGNX $2.67
- P/E Ratio
- MUX N/A
- RGNX N/A
- Revenue Growth
- MUX N/A
- RGNX 74.95
- 52 Week Low
- MUX $6.38
- RGNX $5.04
- 52 Week High
- MUX $24.88
- RGNX $13.93
- Technical
- Relative Strength Index (RSI)
- MUX 50.66
- RGNX 57.58
- Support Level
- MUX $18.34
- RGNX $12.66
- Resistance Level
- MUX $19.80
- RGNX $13.93
- Average True Range (ATR)
- MUX 1.21
- RGNX 0.69
- MACD
- MUX -0.49
- RGNX -0.05
- Stochastic Oscillator
- MUX 4.09
- RGNX 57.85
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.